Euro-Sante :: Euro-Health

Archives for Policy

The relevance of value in establishing the positioning of medicines is the new normal for pharmaceutical marketing. Pharmaceutical companies have customers who are highly constrained by whether healthcare system funding is sustainable long term. Remember, payers think epidemiologically and in multiple years of costed care so industry needs to assess how that can be understood […]

Posted by Mike Tremblay

The AI agenda is for me all about augmenting human reasoning; what I call cognology (cognitive focus) to distinguish from technology (physical focus). This is the core challenge to work flow and adoption. Here are some thoughts on the application of John Boyd’s OODA decision making from military decision making to healthcare decision making. Boyd […]

Posted by Mike Tremblay

From the UK Guardian: private healthcare providers. The research on comparative performance of for profit and not for profit healthcare providers is well developed, so it is surprising to see such a weak quality assessment about private providers in the NHS. The NHS is a very difficult customer for a number of reasons, primarily the glass […]

Posted by Mike Tremblay

How can I be sure the medicine I take is genuine? Counterfeit medicines are a global problem, with trade in the billions of dollars. The World Health Organization estimates 8-10% of all drugs supplied globally are counterfeit. Counterfeits are a clear and present danger to human health. No country is immune from the risk. Fake […]

Posted by Mike Tremblay

This is a summary of some emerging and salient issues related to the UK departure from the EU. Workforce It is estimated that the UK recruits 7000 nurses and 2000 doctors annually from the EU. The UK is currently unable to meet its workforce requirements for the NHS from its domestic higher education system. To […]

Posted by Mike Tremblay

While folks have been quick to jump on the results of the referendum as evidence of democracy at work, (and perhaps that is partly true), a few days later we see the consequences. Economic challenges anew, social discontent in the UK (racism and xenophobia legitimated by the exit vote) and political meltdown in the UK’s […]

Posted by Mike Tremblay

The ERRIN innovation event, The Hospital of the Future, 2 March 2010, explored the future of the hospital as a recipient of financially and environmentally sustainable investment. The key outcome for me, as one of the moderators of the event, was the emerging view of the hospital as a major innovator within their local/regional economies.… » read more

Posted by EuroSante